Jubilant Pharma to sell stake in Sofie Biosciences for $139.43 million
Jubilant Pharmova’s wholly-owned subsidiary, Jubilant Pharma (JPL), on Sunday announced that it is set to divest its entire 25.8
Continue reading
Tag: Trilantic Capital Partners